Literature DB >> 21497511

Human resistin: found in translation from mouse to man.

Daniel R Schwartz1, Mitchell A Lazar.   

Abstract

The discovery of resistin 10 years ago as a fat cell-secreted factor that modulates insulin resistance suggested a link to the current obesity-associated epidemics of diabetes and cardiovascular disease, which are major human health concerns. Although adipocyte-derived resistin is indisputably linked to insulin resistance in rodent models, the relevance of human resistin is complicated because human resistin is secreted by macrophages rather than adipocytes, and because of the descriptive nature of human epidemiology. In this review, we examine the recent and growing evidence that human resistin is an inflammatory biomarker and a potential mediator of diabetes and cardiovascular disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497511      PMCID: PMC3130099          DOI: 10.1016/j.tem.2011.03.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  104 in total

1.  Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production.

Authors:  Michael W Rajala; Silvana Obici; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population.

Authors:  Haruhiko Osawa; Yasuharu Tabara; Ryuichi Kawamoto; Jun Ohashi; Masaaki Ochi; Hiroshi Onuma; Wataru Nishida; Kazuya Yamada; Jun Nakura; Katsuhiko Kohara; Tetsuro Miki; Hideichi Makino
Journal:  Diabetes Care       Date:  2007-03-23       Impact factor: 19.112

3.  Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study.

Authors:  Jian Yu Xu; Pak C Sham; Aimin Xu; Annette W K Tso; Nelson M S Wat; King Yip Cheng; Carol H Y Fong; Edward D Janus; Karen S L Lam
Journal:  Clin Endocrinol (Oxf)       Date:  2007-02       Impact factor: 3.478

4.  Resistin, central obesity, and type 2 diabetes.

Authors:  C L McTernan; P G McTernan; A L Harte; P L Levick; A H Barnett; S Kumar
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

5.  Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome.

Authors:  Silvia Langheim; Lorella Dreas; Lorenzo Veschini; Francesco Maisano; Chiara Foglieni; Santo Ferrarello; Gianfranco Sinagra; Bartolo Zingone; Ottavio Alfieri; Elisabetta Ferrero; Attilio Maseri; Giacomo Ruotolo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-08       Impact factor: 4.733

6.  Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.

Authors:  Dominique Hansen; Paul Dendale; Milou Beelen; Richard A M Jonkers; Annelies Mullens; Luk Corluy; Romain Meeusen; Luc J C van Loon
Journal:  Eur J Appl Physiol       Date:  2010-02-04       Impact factor: 3.078

7.  Role of resistin in cardiac contractility and hypertrophy.

Authors:  Maengjo Kim; Jae Kyun Oh; Susumu Sakata; Iifan Liang; Woojin Park; Roger J Hajjar; Djamel Lebeche
Journal:  J Mol Cell Cardiol       Date:  2008-05-20       Impact factor: 5.000

8.  Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans.

Authors:  Y M Cho; B-S Youn; S S Chung; K W Kim; H K Lee; K-Y Yu; H J Park; H D Shin; K S Park
Journal:  Diabetologia       Date:  2004-01-23       Impact factor: 10.122

9.  Resistin release by human adipose tissue explants in primary culture.

Authors:  John N Fain; Paramjeet S Cheema; Suleiman W Bahouth; M Lloyd Hiler
Journal:  Biochem Biophys Res Commun       Date:  2003-01-17       Impact factor: 3.575

10.  Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.

Authors:  Alexander Koch; Olav A Gressner; Edouard Sanson; Frank Tacke; Christian Trautwein
Journal:  Crit Care       Date:  2009-06-19       Impact factor: 9.097

View more
  116 in total

1.  Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor.

Authors:  Beatriz Sánchez-Solana; Jorge Laborda; Victoriano Baladrón
Journal:  Mol Endocrinol       Date:  2011-11-10

Review 2.  [Adipokines in healthy and obese children].

Authors:  G A Martos-Moreno; J J Kopchick; J Argente
Journal:  An Pediatr (Barc)       Date:  2012-11-24       Impact factor: 1.500

3.  Human resistin protects against endotoxic shock by blocking LPS-TLR4 interaction.

Authors:  Jessica C Jang; Jiang Li; Luca Gambini; Hashini M Batugedara; Sandeep Sati; Mitchell A Lazar; Li Fan; Maurizio Pellecchia; Meera G Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-13       Impact factor: 11.205

4.  The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Evan D Muse; David I Feldman; Michael J Blaha; Zeina A Dardari; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir; Michael H Criqui; Mary Cushman; Robyn L McClelland; Matthew A Allison
Journal:  Atherosclerosis       Date:  2014-12-23       Impact factor: 5.162

5.  Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets.

Authors:  Maria Dalamaga
Journal:  World J Exp Med       Date:  2013-08-20

6.  Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications.

Authors:  Maria Dalamaga
Journal:  World J Exp Med       Date:  2013-08-20

7.  Resistin-induced cardiomyocyte hypertrophy is inhibited by apelin through the inactivation of extracellular signal-regulated kinase signaling pathway in H9c2 embryonic rat cardiomyocytes.

Authors:  Jian-Wei Luo; Xian Zheng; Guan-Chang Cheng; Qun-Hui Ye; Yong-Zhi Deng; Lin Wu
Journal:  Biomed Rep       Date:  2016-09-02

Review 8.  Tissue Immunometabolism: Development, Physiology, and Pathobiology.

Authors:  Kevin Man; Vassily I Kutyavin; Ajay Chawla
Journal:  Cell Metab       Date:  2016-09-29       Impact factor: 27.287

Review 9.  Emerging Roles for Adipose Tissue in Cardiovascular Disease.

Authors:  Elizabeth E Ha; Robert C Bauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

Review 10.  Immunological contributions to adipose tissue homeostasis.

Authors:  Joanna R DiSpirito; Diane Mathis
Journal:  Semin Immunol       Date:  2015-11-24       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.